Lucchinetti C. , Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H.Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol2000; 47: 707—17.
2.
Barnett MH, Prineas JWRelapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol2004; 55: 458—68.
3.
Coles AJ, Wing M., Smith S., Coraddu F., Greer S., Taylor C. et al. Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet1999 ; 354: 1691—95.
4.
Ebers GC, Bulman DE, Sadovnick AD, Paty DW, Warren S., Hader W. et al. A population-based study of multiple sclerosis in twins. N Engl J Med1986; 315: 1638—42.
5.
Sawcer S., Ban M., Maranian M., Yeo TW, Compston A., Kirby A. et al. A high-density screen for linkage in multiple sclerosis. Am J Hum Genet2005; 77: 454—67.
6.
Hammond SR, English DR, McLeod JGThe age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia. Brain2000; 123: 968—74.
McLeod JG, Hammond SR, Hallpike JFEpidemiology of multiple sclerosis in Australia. With NSW and SA survey results . Med J Aust1994; 160: 117—22.
9.
Goldacre MJ, Abisgold JD, Yeates DG, Seagroatt V.Risk of multiple sclerosis after head injury: record linkage study. J Neurol Neurosurg Psychiatry2006; 77: 351—53.
10.
Bangsi D., Ghadirian P., Ducic S., Morisset R., Ciccocioppo S., McMullen E. et al. Dental amalgam and multiple sclerosis: a case-control study in Montreal, Canada. Int J Epidemiol1998; 27: 667—71.
11.
Zorzon M., Zivadinov R., Nasuelli D., Dolfini P., Bosco A., Bratina A. et al. Risk factors of multiple sclerosis: a case-control study. Neurol Sci2003; 24: 242—47.
12.
Riise T., Nortvedt MW, Ascherio A.Smoking is a risk factor for multiple sclerosis. Neurology2003; 61: 1122—24.
13.
Ascherio A. , Munger KL, Lennette ET, Spiegelman D., Hernan MA, Olek MJ et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA2001; 286: 3083—88.
14.
Munger KL, Zhang SM, O'Reilly E., Hernan MA, Olek MJ, Willett WC et al. Vitamin D intake and incidence of multiple sclerosis. Neurology2004; 62: 60—65.
15.
Yang S., Smith C., Prahl JM, Luo X., DeLuca HFVitamin D deficiency suppresses cell-mediated immunity in vivo. Arch Biochem Biophys1993; 303: 98—106.
16.
Eyles D., Almeras L., Benech P., Patatian A., Mackay-Sim A., McGrath J. et al. Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain. J Steroid Biochem Mol Biol2007 ; 103: 538—45.
17.
Ponsonby AL , Lucas RM, van der Mei IAUVR, vitamin D and three autoimmune diseases — multiple sclerosis, type 1 diabetes, rheumatoid arthritis. Photochem Photobiol2005; 81: 1267—75.
18.
van der Mei IA, Ponsonby AL, Dwyer T., Blizzard L., Simmons R., Taylor BV et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. Br Med J2003; 327: 316.
19.
Lucas RM, Ponsonby AL, McMichael AJ, van der Mei IA, Chapman C., Coulthard A. et al. Observational analytical studies in multiple sclerosis: controlling bias through study design and conduct. The Australian Multi-centre study of Environment and Immune Function. Mult Scler2007; 13: 827—39.
20.
Chaudhuri A.Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis. Med Hypotheses2005; 64: 608—18.